North America Small Molecule Drug Discovery Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The North America Small Molecule Drug Discovery Market size is expected to reach US$ 56,040.1 Million by 2031 from US$ 26,303.5 Million in 2023. The market is estimated to record a CAGR of 10.0% from 2023 to 2031.

Executive Summary and North America Small Molecule Drug Discovery Market Analysis:

The North American small molecule drug discovery market is witnessing consistent growth on the back of various drivers. One of the major drivers is growing attention from pharmaceutical and biotechnology firms towards vigorous research and development activities for discovering innovative and efficacious small molecule drugs. The market is experiencing huge investments in the pharma sector, driving sophisticated drug discovery technologies as well as accelerating product development. Also, the rising cases of chronic ailments, particularly cancer, have raised demand for new treatments, further driving the market's growth. The United States leads with its strong research platform, availability of global pharmaceutical companies, and conducive regulatory environment. Canada and Mexico are also exhibiting substantial promise with advancing healthcare infrastructures and increasing government efforts at encouraging biomedical research. Overall, these factors are likely to drive the North American small molecule drug discovery market during the upcoming years.

North America Small Molecule Drug Discovery Market: Strategic Insights

North America Small Molecule Drug Discovery Market Segmentation Analysis:

• By Therapeutic Area, the North America Small Molecule Drug Discovery Market is segmented into Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas. Oncology held the largest share of the market in 2023.
• By Process or Phase, the North America Small Molecule Drug Discovery Market is segmented into Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development. Lead Generation and Refinement held the largest share of the market in 2023.

North America Small Molecule Drug Discovery Market Players Density: Understanding Its Impact on Business Dynamics

The North America Small Molecule Drug Discovery Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Small Molecule Drug Discovery Market Outlook

Artificial intelligence (AI) and associated technologies assist in making drug discovery cost-effective and deriving quick results. It helps by offering innovative ways to collect and manage data, along with reducing dependency on manual operations. Leading biopharmaceutical companies are utilizing AI platforms to accelerate the drug discovery. For instance, Pfizer uses IBM Watson (a machine learning system) to enhance its search for immuno-oncology drugs. Additionally, Sanofi collaborated with a UK-based start-up, Exscientia's AI platform, to discover therapies for treating metabolic diseases. Moreover, Genentech adopts an AI system from GNS Healthcare to explore cancer treatments. AI tools are highly used in screening and identifying compounds and minimizing the drug interactions that may cause issues later.
With the rapid introduction of AI in healthcare, numerous pharmaceutical companies are investing in joint ventures with AI companies for the identification of drug targets and designing new drugs. Therefore, numerous partnerships between pharmaceutical industries, AI companies, and government organizations are rising globally. For instance, in 2023, Merck partnered with BenevolentAI and Exscientia to harness the power of AI-driven design and discovery capabilities, further advancing the company's research efforts. Moreover, in November 2023, Evommune Inc. partnered with Accutar Biotechnology Inc., and focused on the discovery of novel small molecule drug candidates in chronic inflammatory diseases. The collaboration is expected to leverage Accutar's proprietary AI platform as well as Evommune's expertise in the design and development of novel oral small molecule treatments against the root cause of chronic immune-mediated inflammatory diseases. Thus, AI-driven drug discovery is emerging as a significant trend in the small molecule drug discovery market.

North America Small Molecule Drug Discovery Market Country Insights

By country, the North America Small Molecule Drug Discovery Market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2023.

In North America, the US holds a significant share of the small molecule drug discovery market. The increasing prevalence of chronic diseases such as cardiovascular diseases and cancer primarily drives the market growth in the country. As per the American Cancer Society, in 2024, ~2 million people are projected to suffer from new cancer cases, and ~611,000 death cases are expected to be registered in the US. Owing to this scenario, the US health system witnesses massive investments in research and developments for novel drug molecules. Further, a strong drug pipeline, along with therapeutic area approvals for small molecule drugs, is expected to drive the regional market. Apart from the rising number of approved drugs, increasing awareness of advanced therapeutics is likely to be responsible for the growth of the small molecule drug discovery market during the forecast period.

North America Small Molecule Drug Discovery Market Company Profiles

Some of the key players operating in the market include GSK Plc, Charles River Laboratories International Inc, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co, Merck KGaA, ICON Plc, Revvity Inc, Danaher Corp, Thermo Fisher Scientific Inc., Oncodesign Services.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Small Molecule Drug Discovery Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise